The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified-Reference-Cited by-同舟云学术

The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified

Published:2007-09-13 Issue:1 Volume:110 Page:99-109
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Li Wen-Feng,Hu Zhen,Rao Nan-Yan,Song Chuang-Gui,Zhang Bin,Cao Ming-Zhi,Su Feng-Xi,Wang Yong-Sheng,He Ping-Qing,Di Gen-Hong,Shen Kun-Wei,Wu Jiong,Lu Jin-Song,Luo Jian-Min,Liu Xiao-Yi,Zhou Jie,Wang Lei,Zhao Lin,Liu Yan-Bing,Yuan Wen-Tao,Yang Lin,Shen Zhen-Zhou,Huang Wei,Shao Zhi-Ming

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-007-9708-3.pdf

Reference46 articles.

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

2. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324

3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689

4. Weitzel JN (1999) Genetic cancer risk assessment. Putting it all together. Cancer 86:2483–2492

5. (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397–2406

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population;Cancer Pathogenesis and Therapy;2024-04

2. An overview of the research progress of BRCA gene mutations in breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

3. BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers;International Journal of Molecular Sciences;2023-03-05

4. Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer;Cancer Biology & Medicine;2023-03-02

5. Familial Breast Cancer;Holistic Approach to Breast Disease;2023